http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.jpg 144 1 September 2010--Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that it has received conversion requests in respect of http://pharmalicensing.com/redirs/news_rss//public/news/view/530851/4/0/culs-conversion-and-additional-listing http://pharmalicensing.com/redirs/news_rss//public/news/view/530851/4/0/culs-conversion-and-additional-listing Malvern, PA, [September 1, 2010] - Neuronetics, Inc., maker of the NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy http://pharmalicensing.com/redirs/news_rss//public/news/view/530872/4/0/neuronetics-selected-by-world-economic-forum-as-2011-technology-pioneer http://pharmalicensing.com/redirs/news_rss//public/news/view/530872/4/0/neuronetics-selected-by-world-economic-forum-as-2011-technology-pioneer CLEVELAND, August 31, 2010 --Ferro Corporation (NYSE: FOE), announced today the final results of its tender offer for all of its outstanding 6.50% Convertible Senior Notes due 2013 (the... http://pharmalicensing.com/redirs/news_rss//public/news/view/530865/4/0/ferro-corporation-announces-expiration-and-final-results-of-tender-offer-for-its-6-50-convertible-senior-notes-due-2013 http://pharmalicensing.com/redirs/news_rss//public/news/view/530865/4/0/ferro-corporation-announces-expiration-and-final-results-of-tender-offer-for-its-6-50-convertible-senior-notes-due-2013 Ottawa, Ontario/ August 30, 2010 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") announced today that it has completed the initial tranche of an offering of equity... http://pharmalicensing.com/redirs/news_rss//public/news/view/530712/4/0/pharmagap-announces-closing-of-first-tranche-of-private-placement http://pharmalicensing.com/redirs/news_rss//public/news/view/530712/4/0/pharmagap-announces-closing-of-first-tranche-of-private-placement (RANCHO CORDOVA, CA), August 26, 2010--ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said it has filed a... http://pharmalicensing.com/redirs/news_rss//public/news/view/530667/4/0/thermogenesis-announces-reverse-stock-split-effective-on-nasdaq-capital-market-august-27-2010 http://pharmalicensing.com/redirs/news_rss//public/news/view/530667/4/0/thermogenesis-announces-reverse-stock-split-effective-on-nasdaq-capital-market-august-27-2010 NEW HAVEN, Conn., Aug. 18, 2010 -- Achillion Pharmaceuticals, Inc., (Nasdaq:ACHN) a leader in the discovery and development of small molecule drugs to combat the most challenging infectious... http://pharmalicensing.com/redirs/news_rss//public/news/view/530643/4/0/achillion-announces-private-placement-of-50-million http://pharmalicensing.com/redirs/news_rss//public/news/view/530643/4/0/achillion-announces-private-placement-of-50-million (RANCHO CORDOVA, CA), August 11, 2010--ThermoGenesis Corp. (NASDAQ: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that its Board... http://pharmalicensing.com/redirs/news_rss//public/news/view/530668/4/0/thermogenesis-announces-stockholder-authorization-of-reverse-split http://pharmalicensing.com/redirs/news_rss//public/news/view/530668/4/0/thermogenesis-announces-stockholder-authorization-of-reverse-split Malvern, PA, August 10, 2010 - TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series... http://pharmalicensing.com/redirs/news_rss//public/news/view/530759/4/0/tetralogic-pharmaceuticals-completes-32-million-series-c-financing http://pharmalicensing.com/redirs/news_rss//public/news/view/530759/4/0/tetralogic-pharmaceuticals-completes-32-million-series-c-financing lRVINE, CA, June 01, 20 I 0 - PRO-DEX, INC. (NASDAQ: PDEX) today announced that its Board of Directors has detennined to effect a reverse split of the Company's common stock pursuant to authority... http://pharmalicensing.com/redirs/news_rss//public/news/view/530884/4/0/pro-dex-inc-announces-reverse-stock-split-to-be-effective-june-18-2010 http://pharmalicensing.com/redirs/news_rss//public/news/view/530884/4/0/pro-dex-inc-announces-reverse-stock-split-to-be-effective-june-18-2010